A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations

Schizophrenia Bulletin

Volumn 32, Issue SUPPL.1, 2006, Pages

  Van Der Gaag, Mark ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Antipsychotic medicatio; Cognitive behavior therapy; Psychosis; Schizophrenia; Severe mental illness; Symptoms

Indexed keywords

DOPAMINE;

COGNITIVE THERAPY; DELUSION; HALLUCINATION; HUMAN; MEMORY DISORDER; METABOLISM; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; PREFRONTAL CORTEX; REMISSION; REVIEW;

COGNITIVE THERAPY; DELUSIONS; DOPAMINE; HALLUCINATIONS; HUMANS; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; REMISSION INDUCTION;

EID: 34247481106     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbl027     Document Type: Conference Paper

References (100)

1. Liddle PF, Barnes TR, Morris D, Haque S. Three syndromes in chronic schizophrenia. Br J Psychiatry Suppl. 1989;7:119-122
2. Broome MR, Woolley JB, Tabraham P, et al. What causes the onset of psychosisSchizophr Res. 2005;79:23-34
3. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13-23
4. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophr Res. 2005;79:59-68
5. Hohwy J, Rosenberg R. Cognitive neuropsychiatry: conceptual, methodological and philosophical perspectives. World J Biol Psychiatry. 2005;6:192-197
6. Tarrier N. Cognitive behaviour therapy for schizophrenia - a review of development, evidence and implementation. Psychother Psychosom. 2005;74:136-144
7. Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med. 2002;32: 763-782
8. National Institute for Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: National Collaborating Centre for Mental Health; 2002 Retrieved August 9, 2006, from http://www.nice.org.uk/ page.aspxo=CG0019
9. Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev. 2004;4:CD000524
10. Kasper S, Tauscher J, Kufferle B, Barnas C, Pezawas L, Quiner S. Dopamine- and serotonin-receptors in schizophrenia: results of imaging- studies and implications for pharmacotherapy in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1999;249(suppl 4):83-89
11. David AS. Auditory hallucinations: phenomenology, neuropsychology and neuroimaging update. Acta Psychiatr Scand Suppl. 1999;395:95-104
12. Kircher TT, Thienel R. Functional brain imaging of symptoms and cognition in schizophrenia. Prog Brain Res. 2005; 150:299-308
13. Stahl SM. Symptoms and circuits, part 3: schizophrenia. J Clin Psychiatry. 2004;65:8-9
14. Gruzelier JH. Hemispheric imbalances in schizophrenia. Int J Psychophysiol. 1984;1:227-240
15. Crow TJ. Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr Bull. 1990;16:433-443
16. Friston KJ, Frith CD. Schizophrenia: a disconnection syndromeClin Neurosci. 1995;3:89-97
17. Grossberg S. The imbalanced brain: from normal behavior to schizophrenia. Biol Psychiatry. 2000;48:81-98
18. Andreasen NC, Paradiso S, O'Leary DS. ''Cognitive dysmetria'' as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical- cerebellar circuitrySchizophr Bull. 1998;24:203-218
19. Williamson P. Mind, Brain, and Schizophrenia. Oxford, NY: University Press; 2006
20. Braver TS, Barch DM, Cohen JD. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry. 1999;46:312-328
21. Shaner A. Delusions, superstitious conditioning and chaotic dopamine neurodynamics. Med Hypotheses. 1999;52:119-123
22. Blackwood NJ, Bentall RP, Ffytche DH, Simmons A, Murray RM, Howard RJ. Persecutory delusions and the determination of self-relevance: an fMRI investigation. Psychol Med. 2004;34:591-596
23. Williams LM, Das P, Harris AW, et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry. 2004;161:480-489
24. Goto Y, Grace AA. Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization. Neuron. 2005; 47:255-266
25. Goto Y, Grace AA. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci. 2005;8:805-812
26. Weiss AP, Heckers S. Neuroimaging of hallucinations: a review of the literature. Psychiatry Res. 1999;92:61-74
27. Shergill SS, Cameron LA, Brammer MJ, Williams SC, MurrayRM,McGuire PK. Modality specific neural correlates of auditory and somatic hallucinations. J Neurol Neurosurg Psychiatry. 2001;71:688-690
28. Allen PP, Amaro E, Fu CH, Williams SC, Brammer M, Johns LC, McGuire PK. Neural correlates of the misattribution of self-generated speech. Hum Brain Mapp. 2005;26: 44-53
29. Hubl D, Koenig T, Strik W, et al. Pathways that make voices: white matter changes in auditory hallucinations. Arch Gen Psychiatry. 2004;61:658-668
30. Shergill SS, Brammer MJ, Amaro E, Williams SC, Murray RM, McGuire PK. Temporal course of auditory hallucinations. Br J Psychiatry. 2004;185:516-517
31. Hunter MD, Griffiths TD, Farrow TF, et al. A neural basis for the perception of voices in external auditory space. Brain. 2003;126(pt 1):161-169
32. Green MF, Kinsbourne M. Subvocal activity and auditory hallucinations: clues for behavioral treatmentsSchizophr Bull. 1990;16:617-625
33. Gould LN. Verbal hallucinations and activity of vocal musculature. Am J Psychiatry. 1948;105:169-177
34. Margo A, Hemsley DR, Slade PD. The effects of varying auditory input on schizophrenic hallucinations. Br J Psychiatry. 1981;139:122-127
35. Done DJ, Frith CD, Owens DC. Reducing persistent auditory hallucinations by wearing an ear-plug. Br J Clin Psychol. 1986;25(pt 2):151-152
36. van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiatry. 2001; 58:663-668
37. Barrett TR, Etheridge JB. Verbal hallucinations in normals: I. People who hear ''voices.'' Appl Cognit Psychol. 1992;6: 379-387
38. Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res. 2000;97:153-164
39. Schulman CA, Richlin M, Weinstein S. Hallucinations and disturbances of affect, cognition, and physical state as a function of sensory deprivation. Percept Mot Skills. 1967;25: 1001-1024
40. Hunter MD, Eickhoff SB, Miller TW, Farrow TF, Wilkinson ID, Woodruff PW. Neural activity in speechsensitive auditory cortex during silence. Proc Natl Acad Sci U S A. 2005;103:189-194
41. Hemsley DR. An experimental psychological model for schizophrenia. In: Hafner H, Gattaz WF, Janzarik W, eds. Search for the Causes of Schizophrenia. Vol 1. New York, NY: Springer; 1987:179-188
42. Hemsley DR. A simple (or simplistic) cognitive model for schizophrenia. Behav Res Ther. 1993;31:633-645
43. Hemsley DR. The development of a cognitive model of schizophrenia: placing it in context. Neurosci Biobehav Rev. 2005;29:977-988
44. Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 1994;51: 139-154
45. Frith CD. The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med. 1987;17:631-648
46. Frith CD, Blakemore S, Wolpert DM. Explaining the symptoms of schizophrenia: abnormalities in the awareness of action. Brain Res Brain Res Rev. 2000;31(2-3):357-363
47. Corcoran R, Mercer G, Frith CD. Schizophrenia, symptomatology and social inference: investigating ''theory of mind'' in people with schizophrenia. Schizophr Res. 1995;17: 5-13
48. Frith CD. Schizophrenia and theory of mind. Psychol Med. 2004;34:385-389
49. Brune M. ''Theory of mind'' in schizophrenia: a review of the literature. Schizophr Bull. 2005;31:21-42
50. Gilleen J, David AS. The cognitive neuropsychiatry of delusions: from psychopathology to neuropsychology and back again. Psychol Med. 2005;35:5-12
51. Blackwood NJ, Howard RJ, Bentall RP, Murray RM. Cognitive neuropsychiatric models of persecutory delusions. Am J Psychiatry. 2001;158:527-539
52. Maher BA. Anomalous experience and delusional thinking: the logic of explanations. In: Oltmanns TF, Maher BA, eds. Delusional Beliefs. New York, NY: John Wiley; 1988:15-33
53. Freeman D, Garety P, Fowler D, Kuipers E, Bebbington P, Dunn G. Why do people with delusions fail to choose more realistic explanations for their experiencesAn empirical investigation. J Consult Clin Psychol. 2004;72(4):671-680
54. Garety PA, Hemsley DR, Wessely S. Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probabilistic inference task. J Nerv Ment Dis. 1991;179: 194-201
55. Garety P. Reasoning and delusions. Br J Psychiatry Suppl. November 1991;(suppl 14):14-18
56. Huq SF, Garety PA, Hemsley DR. Probabilistic judgements in deluded and non-deluded subjects. Q J Exp Psychol A. 1988;40:801-812
57. Colbert SM, Peters ER. Need for closure and jumping-toconclusions in delusion-prone individuals. J Nerv Ment Dis. 2002;190:27-31
58. Linney YM, Peters ER, Ayton P. Reasoning biases in delusion- prone individuals. Br J Clin Psychol. 1998;37(pt 3): 285-302
59. Mujica-Parodi LR, Corcoran C, Greenberg T, Sackeim HA, Malaspina D. Are cognitive symptoms of schizophrenia mediated by abnormalities in emotional arousalCNS Spectr. 2002;7(1):58-69
60. Fear C, Sharp H, Healy D. Cognitive processes in delusional disorders. Br J Psychiatry. 1996;168:61-67
61. Phillips ML, Senior C, David AS. Perception of threat in schizophrenics with persecutory delusions: an investigation using visual scan paths. Psychol Med. 2000;30:157-167
62. Spitzer M. A neurocomputational approach to delusions. Compr Psychiatry. 1995;36:83-105
63. Baker CA, Morrison AP. Cognitive processes in auditory hallucinations: attributional biases and metacognition. Psychol Med. 1998;28:1199-1208
64. Morrison AP, Wells A. A comparison of metacognitions in patients with hallucinations, delusions, panic disorder, and non-patient controls. Behav Res Ther. 2003;41:251-256
65. Garcia-Montes JM, Perez-Alvarez M, Soto Balbuena C, Perona Garcelan S, Cangas AJ. Metacognitions in patients with hallucinations and obsessive-compulsive disorder: The superstition factor. Behav Res Ther. 2005;44:1091-1104
66. Laroi F, Van der Linden M. Metacognitions in proneness towards hallucinations and delusions. Behav Res Ther. 2005;43:1425-1441
67. Heilbrun AB Jr. Impaired recognition of self-expressed thought in patients with auditory hallucinations. J Abnorm Psychol. 1980;89:728-736
68. Bentall RP, Kaney S, Dewey ME. Paranoia and social reasoning: an attribution theory analysis. Br J Clin Psychol. 1991;30(pt 1):13-23
69. Moritz S,Woodward TS, Ruff CC. Sourcemonitoring andmemory confidence in schizophrenia. Psychol Med. 2003;33:131-139
70. Ensum I, Morrison AP. The effects of focus of attention on attributional bias in patients experiencing auditory hallucinations. Behav Res Ther. 2003;41:895-907
71. Keefe RS, Arnold MC, Bayen UJ, McEvoy JP, Wilson WH. Source-monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources. Schizophr Res. 2002;57:51-67
72. Franck N, Rouby P, Daprati E, Dalery J, Marie-Cardine M, Georgieff N. Confusion between silent and overt reading in schizophrenia. Schizophr Res. 2000;41:357-364
73. Laroi F, Van der Linden M, Marczewski P. The effects of emotional salience, cognitive effort and meta-cognitive beliefs on a reality monitoring task in hallucination-prone subjects. Br J Clin Psychol. 2004;43(pt 3):221-233
74. Garety P, Kuipers E, Fowler D, Freeman D, Bebbington P. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31:189-195
75. Freeman D, Garety PA, Kuipers E, Fowler D, Bebbington PE. A cognitive model of persecutory delusions. Br J Clin Psychol. 2002;41(pt 4):331-347
76. Beck AT, Rector NA. A cognitive model of hallucinations. Cogn Ther Res. 2003;27:19-52
77. Beck AT, Rector NA. Delusions: a cognitive perspective. J Cogn Psychother. 2002;16:455-468
78. Freeman D, Garety PA. Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behav Res Ther. 2003;41:92-947
79. Freeman D, Garety PA, Kuipers E. Persecutory delusions: developing the understanding of belief maintenance and emotional distress. Psychol Med. 2001;31:1293-1306
80. Garety PA, Freeman D, Jolley S, et al. Reasoning, emotions, and delusional conviction in psychosis. J Abnorm Psychol. 2005;114:373-384
81. Swazey J. Chlorpromazine in Psychiatry. Cambridge, MA: Massachusetts Institute of Technology Press; 1974
82. Wykes T, Brammer M, Mellers J, et al. Effects on the brain of a psychological treatment: cognitive remediation therapy: functional magnetic resonance imaging in schizophrenia. Br J Psychiatry. 2002;181:144-152
83. Baxter LRJr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:681-689
84. Furmark T, Tillfors M, Marteinsdottir I, et al. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry. 2002;59:425-433
85. Paquette V, Levesque J, Mensour B, et al. ''Change the mind and you change the brain'': effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage. 2003;18:401-409
86. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical- limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61:34-41
87. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000;157:493-505
88. Lang PJ, Davis M, Ohman A. Fear and anxiety: animal models and human cognitive psychophysiology. J Affect Disord. 2000;61:137-159
89. Liddell BJ, Brown KJ, Kemp AH, et al. A direct brainstemamygdala- cortical 'alarm' system for subliminal signals of fear. Neuroimage. 2005;24:235-243
90. Hariri AR, Mattay VS, Tessitore A, Fera F, Weinberger DR. Neocortical modulation of the amygdala response to fearful stimuli. Biol Psychiatry. 2003;53:494-501
91. Quirk GJ, Gehlert DR. Inhibition of the amygdala: key to pathological statesAnn N Y Acad Sci. 2003;985:263-272
92. Sotres-Bayon F, Cain CK, Ledoux JE. Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry. In press.
93. Anthony W. Recovery from mental illness: The guiding vision of the mental health services in the 1990s. Psychosoc Rehab J. 1993;16:11-23
94. Goel V, Dolan RJ. Explaining modulation of reasoning by belief. Cognition. 2003;87(1):B11-22
95. Link BG, Struening EL, Neese-Todd S, Asmussen S, Phelan JC. Stigma as a barrier to recovery: the consequences of stigma for the self-esteem of people with mental illnesses. Psychiatr Serv. 2001;52:1621-1626
96. Peters E, Garety P. Cognitive functioning in delusions: a longitudinal analysis. Behav Res Ther. 2006;44:481-514
97. Lysaker PH, Carcione A, Dimaggio G, et al. Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life. Acta Psychiatr Scand. 2005;112:64-71
98. Keefe RS, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull. 1999;25:201-222
99. Keefe RS, Poe MP, McEvoy JP, Vaughan A. Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications. Psychopharmacology (Berl). 2003; 169:383-389
100. Allen P, Freeman D, Johns L, McGuire P. Misattribution of self-generated speech in relation to hallucinatory proneness and delusional ideation in healthy volunteers. Schizophr Res. 2006;84:281-288